Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

PaperCitations, authors & open-access status

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 331 citations, 2015 year and gold oa status.

331
Citations
2015
Year
gold
OA Status

Related on ScholarIQ

Wei Peng
Author
Myeloproliferative Neoplasms: Diagnosis and Treatment
Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Topic
Kruppel-like factors research
Topic
Chronic Myeloid Leukemia Treatments
Topic
470M+ articles · free account